CD8A and neoplasm: The RP phage vaccine elicited a remarkable 24‐fold increase in the frequency of neoAg‐specific CD8+ T cells, significantly inhibited tumor growth, and, when combined with immune checkpoint inhibitors (ICIs), eradicated established tumors in ≈75% of treated animals.